Seminar – Kenneth A. Stauderman, Ph.D.

Dr. Stauderman is Co-Founder and Chief Scientific Officer of CalciMedica Inc. Dr. Stauderman received his BA in Psychology from the University of Virginia and his Ph.D. in Pharmacology at the University of Texas Health Science Center at San Antonio.

CalciMedica is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies for life-threatening inflammatory diseases with high unmet need. CalciMedica’s proprietary technology targets the inhibition of CRAC channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are currently no approved therapies.